RhumbLine Advisers’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.42M | Buy |
+955,052
| New | +$4.98M | ﹤0.01% | 1459 |
|
|
2025
Q4 | – | Sell |
-969,157
| Closed | -$4.91M | – | 4158 |
|
|
2025
Q3 | $4.91M | Sell |
969,157
-174,219
| -15% | -$767K | ﹤0.01% | 1451 |
|
|
2025
Q2 | $4.93M | Sell |
1,143,376
-133,791
| -10% | -$661K | ﹤0.01% | 1424 |
|
|
2025
Q1 | $7.7M | Sell |
1,277,167
-25,039
| -2% | -$127K | 0.01% | 1137 |
|
|
2024
Q4 | $5.14M | Buy |
1,302,206
+5,887
| +0.5% | +$26.4K | ﹤0.01% | 1403 |
|
|
2024
Q3 | $7.58M | Sell |
1,296,319
-10,854
| -0.8% | -$53.5K | 0.01% | 1196 |
|
|
2024
Q2 | $5.63M | Sell |
1,307,173
-22,951
| -2% | -$110K | 0.01% | 1330 |
|
|
2024
Q1 | $6.25M | Sell |
1,330,124
-481,662
| -27% | -$1.84M | 0.01% | 1295 |
|
|
2023
Q4 | $8.9M | Sell |
1,811,786
-43,947
| -2% | -$215K | 0.01% | 1121 |
|
|
2023
Q3 | $10.1M | Sell |
1,855,733
-37,144
| -2% | -$298K | 0.01% | 985 |
|
|
2023
Q2 | $17.5M | Buy |
1,892,877
+30,532
| +2% | +$258K | 0.02% | 719 |
|
|
2023
Q1 | $15.3M | Sell |
1,862,345
-22,317
| -1% | -$246K | 0.02% | 744 |
|
|
2022
Q4 | $21M | Buy |
1,884,662
+58,242
| +3% | +$677K | 0.03% | 564 |
|
|
2022
Q3 | $21.7M | Buy |
1,826,420
+43,318
| +2% | +$656K | 0.03% | 497 |
|
|
2022
Q2 | $27.2M | Buy |
1,783,102
+155,356
| +10% | +$2.8M | 0.04% | 404 |
|
|
2022
Q1 | $34.4M | Sell |
1,627,746
-27,820
| -2% | -$599K | 0.04% | 361 |
|
|
2021
Q4 | $39.1M | Buy |
1,655,566
+62,145
| +4% | +$1.33M | 0.05% | 339 |
|
|
2021
Q3 | $32M | Sell |
1,593,421
-28,286
| -2% | -$580K | 0.04% | 374 |
|
|
2021
Q2 | $32.6M | Sell |
1,621,707
-1,741
| -0.1% | -$37.2K | 0.04% | 386 |
|
|
2021
Q1 | $34.5M | Buy |
1,623,448
+93,055
| +6% | +$2M | 0.05% | 349 |
|
|
2020
Q4 | $33.3M | Buy |
1,530,393
+93,539
| +7% | +$1.82M | 0.05% | 358 |
|
|
2020
Q3 | $25.3M | Sell |
1,436,854
-46,822
| -3% | -$871K | 0.04% | 399 |
|
|
2020
Q2 | $27.9M | Buy |
1,483,676
+39,960
| +3% | +$708K | 0.05% | 353 |
|
|
2020
Q1 | $25M | Buy |
1,443,716
+132,815
| +10% | +$2.78M | 0.05% | 324 |
|
|
2019
Q4 | $27.7M | Buy |
1,310,901
+131,384
| +11% | +$2.66M | 0.05% | 366 |
|
|
2019
Q3 | $23.1M | Buy |
1,179,517
+115,353
| +11% | +$2.12M | 0.04% | 398 |
|
|
2019
Q2 | $18.6M | Buy |
1,064,164
+43,644
| +4% | +$786K | 0.03% | 481 |
|
|
2019
Q1 | $18.9M | Buy |
1,020,520
+3,621
| +0.4% | +$64.5K | 0.04% | 462 |
|
|
2018
Q4 | $16.4M | Buy |
1,016,899
+321,245
| +46% | +$5.08M | 0.04% | 493 |
|
|
2018
Q3 | $10.4M | Sell |
695,654
-29,978
| -4% | -$437K | 0.02% | 660 |
|
|
2018
Q2 | $10.2M | Buy |
725,632
+3,453
| +0.5% | +$45.7K | 0.02% | 674 |
|
|
2018
Q1 | $9.39M | Sell |
722,179
-33,795
| -4% | -$433K | 0.02% | 687 |
|
|
2017
Q4 | $10.4M | Buy |
755,974
+53,224
| +8% | +$719K | 0.02% | 670 |
|
|
2017
Q3 | $9.23M | Sell |
702,750
-5,646
| -0.8% | -$72.7K | 0.02% | 709 |
|
|
2017
Q2 | $9.12M | Buy |
708,396
+27,276
| +4% | +$363K | 0.02% | 674 |
|
|
2017
Q1 | $8.78M | Buy |
681,120
+42,554
| +7% | +$544K | 0.02% | 705 |
|
|
2016
Q4 | $7.85M | Buy |
638,566
+132,506
| +26% | +$1.71M | 0.02% | 733 |
|
|
2016
Q3 | $7.47M | Buy |
506,060
+29,744
| +6% | +$450K | 0.02% | 691 |
|
|
2016
Q2 | $7.25M | Buy |
476,316
+37,501
| +9% | +$531K | 0.02% | 663 |
|
|
2016
Q1 | $5.7M | Buy |
438,815
+39,360
| +10% | +$449K | 0.02% | 769 |
|
|
2015
Q4 | $4.6M | Buy |
399,455
+24,355
| +6% | +$278K | 0.01% | 861 |
|
|
2015
Q3 | $4.15M | Buy |
375,100
+44,216
| +13% | +$549K | 0.01% | 903 |
|
|
2015
Q2 | $4.34M | Sell |
330,884
-7,765
| -2% | -$108K | 0.01% | 922 |
|
|
2015
Q1 | $4.99M | Buy |
338,649
+52,375
| +18% | +$778K | 0.01% | 847 |
|
|
2014
Q4 | $3.94M | Buy |
286,274
+13,605
| +5% | +$182K | 0.01% | 922 |
|
|
2014
Q3 | $3.34M | Sell |
272,669
-80
| -0% | -$1.06K | 0.01% | 986 |
|
|
2014
Q2 | $3.61M | Buy |
272,749
+11,227
| +4% | +$149K | 0.01% | 977 |
|
|
2014
Q1 | $3.35M | Sell |
261,522
-6,850
| -3% | -$88K | 0.01% | 1029 |
|
|
2013
Q4 | $3.28M | Sell |
268,372
-13,710
| -5% | -$175K | 0.01% | 1059 |
|
|
2013
Q3 | $3.43M | Buy |
282,082
+5,946
| +2% | +$79.4K | 0.01% | 1008 |
|
|
2013
Q2 | $3.95M | Buy |
+276,136
| New | +$4.35M | 0.01% | 881 |
|
Other funds holding MPT
VPM
VCM
WAM
RhumbLine Advisers's MPT Position: Q1 2026 in Review
RhumbLine Advisers opened a new position in Medical Properties Trust (MPT) in Q1 2026: 955,052 shares worth $4.42M. The stake represents ﹤0.01% of the portfolio and ranks #1459 among its holdings. This is a return to the name: RhumbLine Advisers previously reported a position in MPT as recently as Q3 2025.
RhumbLine Advisers first reported a position in MPT in Q2 2013 and has held it in 51 quarters since. The position peaked at $39.1M in Q4 2021. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.
- RhumbLine Advisers held 955,052 shares of Medical Properties Trust worth $4.42M as of Q1 2026.
- Medical Properties Trust was a new RhumbLine Advisers position in Q1 2026.
- Medical Properties Trust made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #1459 holding.
- RhumbLine Advisers first reported a position in Medical Properties Trust in Q2 2013 and has held it in 51 quarters since.
- RhumbLine Advisers's Medical Properties Trust position peaked at $39.1M in Q4 2021.
- 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.